CoChat

Statin use and pancreatic cancer risk in two prospective cohort studies

Open access
Hamada, Tsuyoshi, Khalaf, Natalia, Yuan, Chen, Babic, Ana, Morales-Oyarvide, Vicente, Qian, Zhi Rong, Nowak, Jonathan Andrew, Ng, Kimmie, Kraft, Peter, Rubinson, Douglas Adam, Stampfer, Meir Jonathan, Giovannucci, Edward Luciano, Fuchs, Charles Stewart, Ogino, Shuji, Wolpin, Brian Matthew · 2018 · Journal of Gastroenterology
Cited by 43

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BackgroundStatins, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are common lipid-lowering agents and may reduce the risk of several cancer types including pancreatic cancer. However, the association between statin use and pancreatic cancer risk has not been fully evaluated in prospective studies.MethodsWe studied the association between statin use and incident pancreatic cancer in 113,059 participants from the prospective Nurses’ Health Study and Health Professionals Follow-up Study. Statin use was self-reported via study questionnaires and updated biennially. Hazard ratios (HRs) and 95% confidence intervals (CIs) for incidence of pancreatic cancer were estimated using multivariable Cox proportional hazards models with adjustment for potential confounders.ResultsIn total, 583 participants developed incident pancreatic cancer during 1.4 million person-years of follow-up. No difference was identified in pancreatic cancer risk for regular versus non-regular statin users (multivariable-adjusted HR 0.98; 95% CI 0.82–1.16). There was no significant heterogeneity in the association of statin use with pancreatic cancer risk between the cohorts. Similarly, longer duration of regular statin use was not associated with decreased risk of pancreatic cancer (Ptrend = 0.65). The results remained similar when we examined statin use status at baseline or accounting for 4-year latency period. We observed no statistically significant effect modification for the association of statin use with pancreatic cancer risk by body mass index, smoking status, or diabetes mellitus status (all Pinteraction > 0.21).ConclusionsRegular statin use was not associated with pancreatic cancer risk in two large prospective cohort studies in the U.S.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00535-018-1430-x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 43

Metadata

Authors
Hamada, T., Khalaf, N., Yuan, C., Babic, A., Morales-Oyarvide, V., Qian, Z. R., Nowak, J. A., Ng, K., Kraft, P., Rubinson, D. A., Stampfer, M. J., Giovannucci, E. L., Fuchs, C. S., Ogino, S., & Wolpin, B. M.
Venue
Journal of Gastroenterology
Published
2018-01-23
Volume
53
Issue
8
Pages
959-966
ISSN
  • 0944-1174 (ISSN-L)
  • 1435-5922
OpenAlex
W2789712742
Cited by
43
References
3
FWCI
1.76
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statin use and pancreatic cancer risk in two prospective cohort studies. https://app.cochat.ai/papers/10.1007/s00535-018-1430-x
The paper
Hamada, T., Khalaf, N., Yuan, C., Babic, A., Morales-Oyarvide, V., Qian, Z. R., Nowak, J. A., Ng, K., Kraft, P., Rubinson, D. A., Stampfer, M. J., Giovannucci, E. L., Fuchs, C. S., Ogino, S., & Wolpin, B. M. (2018). Statin use and pancreatic cancer risk in two prospective cohort studies. Journal of Gastroenterology. https://doi.org/10.1007/s00535-018-1430-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.